Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function-Reference-Cited by-同舟云学术

Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function

Published:2021-01-27 Issue:4 Volume:14 Page:1292-1302
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Fohner Alison E.¹,Dalton Rachel²,Skagen Kasse²,Jackson Konner²,Claw Katrina G.³,Hopkins Scarlett E.⁴,Robinson Renee⁵,Khan Burhan A.⁵,Prasad Bhagwat⁶,Schuetz Erin G.⁷,Nickerson Deborah A.⁸,Thornton Timothy A.⁹,Dillard Denise A.⁵,Boyer Bert B.⁴,Thummel Kenneth E.⁶,Woodahl Erica L.²

Affiliation:

1. Department of Epidemiology University of Washington Seattle Washington USA

2. Department of Biomedical and Pharmaceutical Sciences University of Montana Missoula Montana USA

3. Division of Biomedical Informatics and Personalized Medicine University of Colorado Aurora Colorado USA

4. Department of Obstetrics and Gynecology Oregon Health & Science University Portland Oregon USA

5. Southcentral Foundation Anchorage Alaska USA

6. Department of Pharmaceutics University of Washington Seattle Washington USA

7. Department of Pharmaceutical Sciences St. Jude Children’s Research Hospital Memphis Tennessee USA

8. Department of Genome Sciences University of Washington Seattle Washington USA

9. Department of Biostatistics University of Washington Seattle Washington USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12970

Reference52 articles.

1. Phenotype–genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles

2. Genetic contribution to variable human CYP3A-mediated metabolism

3. Functional Gene Variants of CYP3A4

4. The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP ) Allele Nomenclature Database

5. Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The influence of drug-induced metabolic enzyme activity inhibition and CYP3A4 gene polymorphism on aumolertinib metabolism;Frontiers in Pharmacology;2024-05-24

2. Cost-effectiveness analysis of CYP3A5 genotype-guided tacrolimus dosing in solid organ transplantation using real-world data;The Pharmacogenomics Journal;2024-05-15

3. Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations;Pharmacogenomics;2024-03

4. Implementing community-engaged pharmacogenomics in Indigenous communities;Nature Communications;2024-01-31

5. Engaging diversity in research: does your drug work in overlooked populations?;Overcoming Obstacles in Drug Discovery and Development;2023